Brainstorm names new CEO

Brainstorm Therapeutics (BCLI) appoints Tony Fiorino CEO. Mr. Fiorino's background includes managing a healthcare equity fund and founding EnzymeRx, a company he ultimately sold to 3SBio.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs